<DOC>
	<DOCNO>NCT01053234</DOCNO>
	<brief_summary>The purpose study patient type 2 diabetes investigate acute effect postprandial blood glucose level modify two different insulin treatment regimens coagulation activation , inflammation endothelial cell function . The investigator hypothesize rapid-acting insulin analogue aspart beneficial postprandial effect coagulation , endothelial dysfunction inflammation compare intermediate-acting insulin NPH due ability lower postprandial glycaemia .</brief_summary>
	<brief_title>Different Insulin Regimens Postprandial Coagulation Activation</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>age 3075 year BMI &gt; 25 kg/m2 type 2 diabetes 4 year pharmacological antidiabetic treatment insulin NPH bedtime insulin aspart meal 24 month metformin stable dose &gt; 1000 mg/d 12 week acetylsalicylic acid ( 75 mg/d ) 2 week antidiabetic treatment 3 month previously HbA1c &lt; 8.5 % recruitment . creatinine &gt; 120 Âµmol/l ALAT /ASAT &gt; 2.5 x upper reference limit use anticoagulant within 1 month previously change dose statin within 1 month previously night work present plan pregnancy mental sickness alcohol abuse clinically relevant major organ systemic illness uncontrolled hypertension &gt; 180/110 mmHg steroid treatment know suspect allergy trial medication .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Hyperglycaemia</keyword>
	<keyword>Postprandial</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Cardiovascular risk marker</keyword>
</DOC>